-
effectivehealthcare.ahrq.gov/sites/default/files/mrsascreening_protocol_20110602.pdf
August 10, 2017 - Announcements
Aug. 1, 2017
Management of Insomnia Disorder
-
effectivehealthcare.ahrq.gov/sites/default/files/20090427identtifyingtopics.pdf
August 10, 2017 - Announcements
Aug. 1, 2017
Management of Insomnia Disorder
-
effectivehealthcare.ahrq.gov/sites/default/files/decision-models-guidance-160915.pdf
August 10, 2017 - Announcements
Aug. 1, 2017
Management of Insomnia Disorder
-
effectivehealthcare.ahrq.gov/sites/default/files/module-i-ahrqs-vision-for-theory-and-principles-of-stakeholder-engagement.pdf
August 10, 2017 - Announcements
Aug. 1, 2017
Management of Insomnia Disorder
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/aggression_research-protocol.pdf
October 05, 2015 - likelihood of receiving treatment that effectively treats the psychiatric disorder (if the
aggression … Adult individuals (ages 18 or older) with an identified psychiatric
disorder, including substance use … disorder,!
including!substance!use!disorders!and!
delirium!(but!not!dementia),!or!with!severe! … disorder)!
•! Any!intervention,!or!combination!of!
interventions,!different!from!seclusion!and! … Also, they will include any psychiatric or substance use disorder, as well as
delirium.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-disorders-imaging_disposition-comments.pdf
November 01, 2011 - Emerging MRI Technologies for Imaging Musculoskeletal Disorders under Loading Stress
Source: http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-
reports/?pageaction=displayproduct&productID=578
Published Online: August 2010
Comparative Effectiveness Research Review Dispositio…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tonsillectomy_executive.pdf
January 01, 2017 - Tonsillectomy for Obstructive Sleep-Disordered Breathing or Recurrent Throat Infection in Children
1
Comparative Effectiveness Review
Number 183
Tonsillectomy for Obstructive Sleep-Disordered
Breathing or Recurrent Throat Infection in
Children
Executive Summary
Introduction
Tonsillectomy or adenotonsillectomy…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fibromyalgia_executive.pdf
January 01, 2015 - Severity Scale, and (2)
a requirement of symptoms for at least 3
months and the absence of another disorder … severity of pain or impairment at baseline,11
presence of a concomitant mood or other mental health
disorder … ).
6
• The most commonly addressed subgroup was adults
with fibromyalgia and major depressive disorder … Three RCTs provided insufficient evidence for
duloxetine treatment and generalized anxiety disorder … duloxetine with placebo in the treatment of
fibromyalgia patients with or without major depressive disorder
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F-5.xlsx
January 01, 2022 - severity at previous study wave, age, sex, duration of pain, oral morphine equivalent, generalized anxiety disorder … lifetime International Statistical Classification of Diseases and Related Health Problems, substance use disorder
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-table-F5.xlsx
January 01, 2022 - severity at previous study wave, age, sex, duration of pain, oral morphine equivalent, generalized anxiety disorder … lifetime International Statistical Classification of Diseases and Related Health Problems, substance use disorder
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief2-opioid-withdrawal.pdf
April 01, 2021 - therapies, enhanced risk mitigation, transition
to buprenorphine, or evaluation for potential opioid use disorder … Tapering may even uncover
underlying opioid use disorder, which requires appropriate evaluation and … We did find a third systematic review that described mobile
applications for opioid use disorder (presence … to assist in tapering of patients who have not been diagnosed with an opioid use
disorder is an off-label … Technologies for opioid use disorder
management: mobile app search and scoping
review.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-brief2-opioid-withdrawal.pdf
April 01, 2021 - therapies, enhanced risk mitigation, transition
to buprenorphine, or evaluation for potential opioid use disorder … Tapering may even uncover
underlying opioid use disorder, which requires appropriate evaluation and … We did find a third systematic review that described mobile
applications for opioid use disorder (presence … to assist in tapering of patients who have not been diagnosed with an opioid use
disorder is an off-label … Technologies for opioid use disorder
management: mobile app search and scoping
review.
-
effectivehealthcare.ahrq.gov/sites/default/files/06_devdelays_potential_high_impact_2012-12-10.pdf
January 01, 2012 - diagnosis, treatment, and
services for developmental disorders including attention-deficit hyperactivity disorder
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-256-telehealth-women-preventive-services-executive-summary.pdf
June 01, 2022 - of repeat IPV, depression, fear of partner, coercive control, self-
efficacy, post-traumatic stress disorder … reversible contraception; NA= not applicable; OCPs=oral contraceptive pills; PTSD=post-traumatic stress
disorder
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-epilepsy-amended-protocol.pdf
March 07, 2021 - neurostim*
9 Harms anhidrosis/de OR 'adverse event'/de OR 'adverse drug
reaction'/de OR 'behavior disorder … '/de OR 'cognitive
defect'/de OR 'developmental delay'/de OR
'developmental disorder'/de OR dystonia … loss of appetite'/de OR 'motor
dysfunction'/de OR 'organ damage'/de OR 'patient
harm'/de OR 'sleep disorder … OR ((cognitiv* OR behavior* OR develop* OR
motor OR movement OR neurodevelop*) NEAR/3
(effect* OR disorder … * OR problem* OR symptom*))
OR ((cognitiv* OR develop* OR neurodevelopment*)
NEAR/3 (delay* OR disorder
-
effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
June 01, 2013 - ES-3
Central Nervous System Disorder Intervention ................................................. … Central Nervous System Disorder Intervention
Dimethyl Fumarate (Tecfidera) for Treatment of Relapsing … Potential for High Impact: High
Genetic Disorder Intervention
Icatibant (Firazyr) for Acute … Hereditary Angioedema
Key Facts: Acute hereditary angioedema (HAE) results from a genetic disorder … Potential for High Impact: High
Sensory Disorder Interventions
Recombinant Human Ocriplasmin
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2_0_0.xlsx
May 29, 2025 - severity at previous study wave, age, sex, duration of pain, oral morphine equivalent, generalized anxiety disorder … lifetime International Statistical Classification of Diseases and Related Health Problems, substance use disorder
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Table-E5_0.xlsx
May 29, 2025 - severity at previous study wave, age, sex, duration of pain, oral morphine equivalent, generalized anxiety disorder … lifetime International Statistical Classification of Diseases and Related Health Problems, substance use disorder
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_research-protocol.pdf
January 27, 2012 - Alcohol-misuse-drug-therapy-140326
…
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/updating-pharmacotherapy-adults-alcohol